Work

A phase II study of a 3-day schedule with topotecan and cisplatin every three weeks in patients with previously in treated small cell lung cancer and extensive disease: Final results

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.7207

Authors: U. Lassen, M. Sørensen, P. B. Jensen, S. W. Langer, B. B. Jensen, N. Jeppesen, C. Rytter, A. Mellemgaard, O. Hansen, K. Østerlind

Institutions: Roskilde Sygehus, Odense University Hospital, Herlev Hospital, Rigshospitalet, Vejle Sygehus

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2604112126

Cites:

Cited by: 3

Related to: 10